GlobeNewswire Inc | Nov 9, 2020 01:00PM EST

November 09, 2020

NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc.(OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday, November 16, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2020. The financial results will be issued in a press release prior to the call.

Conversion Labs management will host the conference call followed by a question and answer period.

Date: Monday, November 16, 2020Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-free dial-in number: 1-800-430-8332International dial-in number: 1-720-452-9103Conference ID: 9683420

The conference call will be webcast live and available for replay here as well as via a link in the Investors section of the companys website at ir.conversionlabs.com.

Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact CMA at 1-949-432-7566.

A replay of the call will be available after 7:30 p.m. Eastern time on the same day through November 30, 2020.

Toll-free replay number: 1-844-512-2921International replay number: 1-412-317-6671Replay ID: 9683420

About Conversion LabsConversion Labs, Inc. is a telemedicine company with a portfolio of online direct-to-consumer brands. The companys brands combine virtual medical treatment with prescription medications and unique over-the-counter products. Its network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the U.S. To learn more, visit Conversionlabs.com.

Company ContactConversion LabsJuan Manuel Pieiro DagneryCFOEmail Contact

Media and Investor Relations ContactRon Both or Grant StudeCMA Investor RelationsTel (949) 432-7566Email Contact